StonvexLoading…
StonvexStonvexStonvexCore line items from AGYS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 | Annual 2022 2022-03-31 |
|---|---|---|---|---|
Revenue | $275.62M | $237.46M | $198.06M | $162.64M |
Operating Income | $22.59M | $15.75M | $12.88M | $6.32M |
Net Income | $23.23M | $86.19M | $14.58M | $6.48M |
EPS (Diluted) | $0.82 | $3.17 | $0.49 | $0.18 |
Total Assets | $434.37M | $350.43M | $243.04M | $214.16M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $73.04M | $144.89M | $112.84M | $96.97M |
Free Cash Flow OCF − CapEx | $52.34M | $40.06M | $27.23M | $27.28M |
Shares Outstanding | 28.02M | 27.38M | 25.33M | 24.73M |